Artificial Oxygen Carrier With Pharmacologic Actions of Adenosine-5′-Triphosphate, Adenosine, and Reduced Glutathione Formulated to Treat an Array of Medical Conditions-Reference-Cited by-同舟云学术

Artificial Oxygen Carrier With Pharmacologic Actions of Adenosine-5′-Triphosphate, Adenosine, and Reduced Glutathione Formulated to Treat an Array of Medical Conditions

Published:2014-07-01 Issue:8 Volume:38 Page:684-690
ISSN:0160-564X
Container-title:Artificial Organs
language:en
Short-container-title:Artificial Organs

Author:

Simoni Jan¹²,Simoni Grace¹²,Moeller John F.¹²,Feola Mario²,Wesson Donald E.³

Affiliation:

1. Division of Artificial Oxygen Carriers; Texas HemoBioTherapeutics & BioInnovation Center (THBBC); Lubbock TX USA

2. School of Medicine; Texas Tech University Health Sciences Center; Lubbock TX USA

3. Scott and White Healthcare; Texas A&M College of Medicine; Temple TX USA

Publisher

Wiley

Subject

Biomedical Engineering,General Medicine,Biomaterials,Medicine (miscellaneous),Bioengineering

Reference43 articles.

1. How safe is blood, really?;Klein;Biologicals,2010

2. Variant Creutzfeld-Jakob disease: risk of transmission by blood transfusion and blood therapies;Ironside;Haemophilia,2006

3. World Health Organization Ten facts on blood transfusion 2013 http://www.who.int/features/factfiles/blood_transfusion/en/

4. Bad blood: the risk of red cell storage;Lee;Nat Med,2010

5. Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction;Shishehbor;JACC Cardiovasc Interv,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microfluidic dual picoinjection based encapsulation of hemoglobin in alginate microcapsules reinforced by a poly(l-lysine)-g-poly(ethylene glycol);Soft Matter;2023

2. From hemoglobin allostery to hemoglobin-based oxygen carriers;Molecular Aspects of Medicine;2022-04

3. Hemoglobin-Based Blood Substitute with Pharmacological Activities of ATP, Adenosine and Reduced Glutathione: A Review of Preclinical and Early Clinical Experience;Blood Substitutes and Oxygen Biotherapeutics;2022

4. Stepping stones to the future of haemoglobin-based blood products: clinical, preclinical and innovative examples;Biomaterials Science;2021

5. Synthetic Blood Substitutes;Trauma Induced Coagulopathy;2020-10-13